TOURMALINE BIO INC (TRML)

US89157D1054 - Common Stock

14.64  -0.4 (-2.66%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-3-31)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
42.62M45.41M76.28M47.51M22.68M
Research and Development
29.63M32.37M56.81M34.25M15.28M
Selling, General, and Administrative Expenses
13.00M13.04M19.47M13.26M7.41M
Operating Income
-42.62M-45.41M-76.28M-47.51M-22.68M
Interest Income/Expense
N/AN/A900.00K800.00K400.00K
Other Income/Expense
4.81M3.29M1.68M-1.13M-420.00K
Non Recurring Items
N/AN/A-200.00KN/AN/A
Income Before Taxes
-32.95M-42.12M-73.89M-47.83M-22.71M
Net Income
-32.95M-42.12M-73.89M-47.83M-22.71M
EBITDA
-43.02M-45.38M-74.90M-46.89M-22.23M
 
Per Share Data
EPS Diluted Total Ops
-5.35-8.87-17.93-11.69-5.51
Non GAAP EPS
N/AN/A-17.90-5.53N/A
 
Statistics

All data in USD

Charts